Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: Lilly’s Alzheimer’s drug slowed cognitive decline; most EU countries back plan to push production of key drugs

    A new Eli Lilly Alzheimer's treatment slowed the rate of cognitive and functional decline in patients by 35% compared to placebo.
    by Ed Silverman May 03, 2023 1 minute
    Source: Alex Hogan/STAT

    Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember, there are only a

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Drug For Lung Cancer, A Novo Plant Fire, And More
    The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other options.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Takeda Restructuring, Pfizer Settling Zantac Suits, And More
    Pfizer agreed to settle more than 10,000 cases accusing it of hiding cancer risks of its Zantac heartburn drug.

    Related Books & Audiobooks